Biotech Research and Innovation Centre, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Nat Cell Biol. 2019 Mar;21(3):311-318. doi: 10.1038/s41556-019-0282-9. Epub 2019 Feb 25.
Genotoxic DNA double-strand breaks (DSBs) can be repaired by error-free homologous recombination (HR) or mutagenic non-homologous end-joining. HR supresses tumorigenesis, but is restricted to the S and G2 phases of the cell cycle when a sister chromatid is present. Breast cancer type 1 susceptibility protein (BRCA1) promotes HR by antagonizing the anti-resection factor TP53-binding protein 1(53BP1) (refs. ), but it remains unknown how BRCA1 function is limited to the S and G2 phases. We show that BRCA1 recruitment requires recognition of histone H4 unmethylated at lysine 20 (H4K20me0), linking DSB repair pathway choice directly to sister chromatid availability. We identify the ankyrin repeat domain of BRCA1-associated RING domain protein 1 (BARD1)-the obligate BRCA1 binding partner-as a reader of H4K20me0 present on new histones in post-replicative chromatin. BARD1 ankyrin repeat domain mutations disabling H4K20me0 recognition abrogate accumulation of BRCA1 at DSBs, causing aberrant build-up of 53BP1, and allowing anti-resection activity to prevail in S and G2. Consequently, BARD1 recognition of H4K20me0 is required for HR and resistance to poly (ADP-ribose) polymerase inhibitors. Collectively, this reveals that BRCA1-BARD1 monitors the replicative state of the genome to oppose 53BP1 function, routing only DSBs within sister chromatids to HR.
遗传毒性 DNA 双链断裂 (DSBs) 可通过无差错同源重组 (HR) 或致突变非同源末端连接修复。HR 抑制肿瘤发生,但仅在存在姐妹染色单体时,在细胞周期的 S 和 G2 期受到限制。乳腺癌 1 型易感性蛋白 (BRCA1) 通过拮抗抗切除因子 TP53 结合蛋白 1(53BP1) 促进 HR(参考文献),但 BRCA1 功能如何仅限于 S 和 G2 期仍不清楚。我们表明,BRCA1 的募集需要识别组蛋白 H4 赖氨酸 20 未甲基化 (H4K20me0),将 DSB 修复途径选择直接与姐妹染色单体的可用性联系起来。我们确定 BRCA1 相关环指结构域蛋白 1 (BARD1) 的锚蛋白重复结构域 - BRCA1 的必需结合伙伴 - 作为新组蛋白中存在的 H4K20me0 的读取器在后复制染色质中。使 BRCA1 在 DSB 处的积累失活的 BARD1 锚蛋白重复结构域突变导致 53BP1 的异常积累,并允许抗切除活性在 S 和 G2 中占主导地位。因此,BARD1 识别 H4K20me0 是 HR 和对聚 (ADP-核糖) 聚合酶抑制剂的抗性所必需的。总的来说,这表明 BRCA1-BARD1 监测基因组的复制状态以拮抗 53BP1 功能,仅将姐妹染色单体内的 DSBs 路由到 HR。